Skip to main content
. 2002 Jun;46(6):1896–1905. doi: 10.1128/AAC.46.6.1896-1905.2002

TABLE 2.

Plasma vRNA load in patients treated with a 30-mg dose of T-20

Day Subjecta
30-1 30-2 30-3 30-4
0 5.71 4.25 4.93 4.50
3 5.52 3.98 4.58 4.29
7 5.26 4.11 4.22 3.64
10 5.10 4.48 4.09 3.32
14 5.13 4.76 4.26 3.73
a

Four individuals were administered 30 mg of T-20 twice daily. The numbers represent plasma vRNA loads (log10) over the course of 14 days of treatment, as determined by bDNA (Chiron Inc.) testing.